TrialNature medicine2021

Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial.

Aditi R Saxena et al.PubMed ↗Publisher ↗

No numbers read from the abstract.